Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Cash Flow Quality Index
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. cash flow quality index. Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (301096) has a Cash Flow Quality Index of 0.33x as of December 2023. Operating cash flow of CN¥90.45 Million is below net income of CN¥271.97 Million, suggesting accrual-heavy earnings not yet converted to cash. See Hangzhou Bio-Sincerity Pharma-Tech Co.Lt free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (2019–2023)
Cash flow quality index of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. from 2019 to 2023. Historical Cash Flow Quality Index for Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 301096 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Cash Flow Quality Index by Year (2019–2023)
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. cash flow quality index by year from 2019 to 2023. Year-by-year earnings quality comparison for Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.. For the full cash flow conversion analysis, see cash efficiency ratio of Hangzhou Bio-Sincerity Pharma-Tech Co.Lt.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.33x | CN¥90.45 Million | CN¥271.97 Million | ▼ -75.1% |
| 2022 | 1.34x | CN¥259.41 Million | CN¥194.16 Million | ▲ +2.0% |
| 2021 | 1.31x | CN¥145.42 Million | CN¥110.97 Million | ▲ +38.4% |
| 2020 | 0.95x | CN¥54.36 Million | CN¥57.40 Million | ▼ -41.2% |
| 2019 | 1.61x | CN¥71.47 Million | CN¥44.40 Million | — |